In any clinical research program, standardized patient care and patient data are the most fundamental and valuable resources. The Clinical and Data Management Core (CDMC) is designed to be supportive of and responsive to clinical research in a clinical environment that is increasingly dependent on electronic data. Specifically, the CDMC will create an Electronic Health Record (EHR)-based Sickle Cell Registry (SCR) to permit real time and efficient data entry at the point of contact with the patient. The CDMC recognizes and will reconcile the differing and often conflicting requirements of EHR data entered for purely clinical purposes with data entered for research. The EHR-based SCR will permit data to be entered once and jointly serve clinicaland research needs. The CDMC will create best practice standards for clinical care and clinical research using EHR-based tools for implementation and monitoring. The creation and enforcement of best practice standards will reduce well-known and avoidable barriers to care affecting the outcomes of patients with sickle cell disease. Standardization of best practices will be the cornerstone of a productive clinical research program. The expertise in the CDCM, the EHR will be an integral part of a quality-driven clinical research program in sickle cell disease. Lastly, the CDMC will aim to develop a clinical research program that has sufficient patient numbers with detailed annotation of clinical data and biospecimens to permit future involvement in multi-center cooperative group and industry-sponsored clinical research in sickle cell disease. The tools and expertise of the CDMC is applied herein to sickle cell disease. However, the EHR-based tools created and the expertise of the CDMC can be applied to any disease. The CDMC merges available expertise in Health Informations with Bioinformatics to create a fully sustainable and broadly applicable core resource. Systems to ensure EHR data accuracy, completeness and quality are a limiting factor in any clinical research program. Sustainablility of the CDMC will be assured by the application of this technology and expertise to other chronic and orphan diseases of childhood.

Public Health Relevance

Patient care and clinical research is increasingly dependent on electronic health records (EHR). Data management systems need to be responsive to both the clinical and research demands on the data for maximal efficiency and data accuracy. The Clinical and Data Management Core will create EHR-based systems to jointly meet the requirements of clinical care and clinical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Exploratory Grants (P20)
Project #
1P20GM109021-01
Application #
8662852
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-04-30
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Alfred I. Du Pont Hosp for Children
Department
Type
DUNS #
City
Wilmington
State
DE
Country
United States
Zip Code
19803
Bialk, Pawel; Wang, Yichen; Banas, Kelly et al. (2018) Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells In Vitro and in a Xenograft Mouse Model. Mol Ther Oncolytics 11:75-89
Modarai, Shirin R; Man, Dula; Bialk, Pawel et al. (2018) Efficient Delivery and Nuclear Uptake Is Not Sufficient to Detect Gene Editing in CD34+ Cells Directed by a Ribonucleoprotein Complex. Mol Ther Nucleic Acids 11:116-129
Bloh, Kevin M; Bialk, Pawel A; Gopalakrishnapillai, Anilkumar et al. (2017) CRISPR/Cas9-Directed Reassignment of the GATA1 Initiation Codon in K562 Cells to Recapitulate AML in Down Syndrome. Mol Ther Nucleic Acids 7:288-298
Rivera-Torres, Natalia; Banas, Kelly; Bialk, Pawel et al. (2017) Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides. PLoS One 12:e0169350
Bialk, Pawel; Sansbury, Brett; Rivera-Torres, Natalia et al. (2016) Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides. Sci Rep 6:32681